IL-6 and tumor necrosis factor-alpha TNF-α are well-established mediators of systemic inflammation and have been consistently associated with disease severity and exacerbation frequency in COPD [13,14,15]. The gene discussed is TNF; the disease is chronic obstructive pulmonary disease.